PamGene, Nottingham University, CombiMatrix, Myriad Genetics, Korea Food and Drug Administration, Centre for Applied Genomics Microarray Facility, Invitrogen, University of Texas Southwestern Medical Center, Cepheid | GenomeWeb

PamGene Sells Nottingham University License for its 3D Microarray Platform

PamGene International of Den Bosch, The Netherlands, on Monday said that it has licensed its three-dimensional, flow-through microarray platform technology to Nottingham University in England.

According to the company, the service license includes the sale of a PamGene four-array PamStation and will allow the university to develop multiplex amplifiable probe hybridization as a service on the PamGene platform.

Financial terms of the licensing deal were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.